CYCLERION THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax
CYCLERION THERAPEUTICS, INC. (CYCN) reported Other Comprehensive Income (Loss), Net of Tax of -$7.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2021-04-30
- CYCLERION THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2020-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2020-09-30 was $3.00K, a 40.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2020-06-30 was -$12.00K.
- CYCLERION THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2020-03-31 was $2.00K.
- CYCLERION THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2020 was -$7.00K.
- CYCLERION THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2019 was -$20.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.00K derived: sum of 2 quarters · filed 2021-02-25 | -$9.00K derived: sum of 3 quarters · filed 2021-02-25 | -$7.00K 10-K · filed 2021-02-25 | |
| 2020-09-30 | $3.00K 10-Q · filed 2020-11-05 | -$9.00K derived: sum of 2 quarters · filed 2020-11-05 | -$7.00K 10-Q · filed 2020-11-05 | -$28.00K derived: sum of 4 quarters · filed 2021-04-30 | |
| 2020-06-30 | -$12.00K 10-Q · filed 2020-08-03 | -$10.00K 10-Q · filed 2020-08-03 | -$31.00K derived: sum of 3 quarters · filed 2021-04-30 | -$26.00K derived: sum of 4 quarters · filed 2021-04-30 | |
| 2020-03-31 | $2.00K 10-Q · filed 2021-04-30 | -$19.00K derived: sum of 2 quarters · filed 2021-04-30 | -$14.00K derived: sum of 3 quarters · filed 2021-04-30 | -$18.00K derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-12-31 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$16.00K derived: sum of 2 quarters · filed 2021-02-25 | -$20.00K derived: sum of 3 quarters · filed 2021-02-25 | -$20.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $5.00K 10-Q · filed 2020-11-05 | $1.00K 10-Q · filed 2019-11-12 | $1.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$4.00K 10-Q · filed 2020-08-03 | -$4.00K 10-Q · filed 2020-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |